Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease.

Urabe S, Isomoto H, Ishida T, Maeda K, Inamine T, Kondo S, Higuchi N, Sato K, Uehara R, Yajima H, Machida H, Chen CC, Fukuda Y, Takeshima F, Nakao K, Tsukamoto K.

Biomed Res Int. 2015;2015:416838. doi: 10.1155/2015/416838. Epub 2015 Oct 19.

2.

IκBζ is a key driver in the development of psoriasis.

Johansen C, Mose M, Ommen P, Bertelsen T, Vinter H, Hailfinger S, Lorscheid S, Schulze-Osthoff K, Iversen L.

Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):E5825-33. doi: 10.1073/pnas.1509971112. Epub 2015 Oct 12.

3.

A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis.

Wu L, Chen X, Zhao J, Martin B, Zepp JA, Ko JS, Gu C, Cai G, Ouyang W, Sen G, Stark GR, Su B, Vines CM, Tournier C, Hamilton TA, Vidimos A, Gastman B, Liu C, Li X.

J Exp Med. 2015 Sep 21;212(10):1571-87. doi: 10.1084/jem.20150204. Epub 2015 Sep 7.

PMID:
26347473
4.

TRAF3, ubiquitination, and B-lymphocyte regulation.

Lin WW, Hostager BS, Bishop GA.

Immunol Rev. 2015 Jul;266(1):46-55. doi: 10.1111/imr.12299.

PMID:
26085206
5.

IL-17 cytokines in immunity and inflammation.

Jin W, Dong C.

Emerg Microbes Infect. 2013 Sep;2(9):e60. doi: 10.1038/emi.2013.58. Epub 2013 Sep 18. Review.

6.

Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci.

Tsoi LC, Spain SL, Ellinghaus E, Stuart PE, Capon F, Knight J, Tejasvi T, Kang HM, Allen MH, Lambert S, Stoll SW, Weidinger S, Gudjonsson JE, Koks S, Kingo K, Esko T, Das S, Metspalu A, Weichenthal M, Enerback C, Krueger GG, Voorhees JJ, Chandran V, Rosen CF, Rahman P, Gladman DD, Reis A, Nair RP, Franke A, Barker JN, Abecasis GR, Trembath RC, Elder JT.

Nat Commun. 2015 May 5;6:7001. doi: 10.1038/ncomms8001.

7.

Human colon carcinogenesis is associated with increased interleukin-17-driven inflammatory responses.

Xie Z, Qu Y, Leng Y, Sun W, Ma S, Wei J, Hu J, Zhang X.

Drug Des Devel Ther. 2015 Mar 18;9:1679-89. doi: 10.2147/DDDT.S79431. eCollection 2015.

8.

CIKS/DDX3X interaction controls the stability of the Zc3h12a mRNA induced by IL-17.

Somma D, Mastrovito P, Grieco M, Lavorgna A, Pignalosa A, Formisano L, Salzano AM, Scaloni A, Pacifico F, Siebenlist U, Leonardi A.

J Immunol. 2015 Apr 1;194(7):3286-94. doi: 10.4049/jimmunol.1401589. Epub 2015 Feb 20.

PMID:
25710910
9.

IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction.

Chen C, Zhang Q, Liu S, Parajuli KR, Qu Y, Mei J, Chen Z, Zhang H, Khismatullin DB, You Z.

Prostate. 2015 Jun;75(8):883-95. doi: 10.1002/pros.22971. Epub 2015 Feb 14.

PMID:
25683512
10.

TRAF4-SMURF2-mediated DAZAP2 degradation is critical for IL-25 signaling and allergic airway inflammation.

Zepp JA, Wu L, Qian W, Ouyang W, Aronica M, Erzurum S, Li X.

J Immunol. 2015 Mar 15;194(6):2826-37. doi: 10.4049/jimmunol.1402647. Epub 2015 Feb 13.

PMID:
25681341
11.

Proinflammatory effects and molecular mechanisms of interleukin-17 in intestinal epithelial cell line HT-29.

Wang YL, Fang M, Wang XM, Liu WY, Zheng YJ, Wu XB, Tao R.

World J Gastroenterol. 2014 Dec 21;20(47):17924-31. doi: 10.3748/wjg.v20.i47.17924.

12.

AZD5363 Inhibits Inflammatory Synergy between Interleukin-17 and Insulin/Insulin-Like Growth Factor 1.

Chen C, Zhang Q, Liu S, Lambrechts M, Qu Y, You Z.

Front Oncol. 2014 Dec 1;4:343. doi: 10.3389/fonc.2014.00343. eCollection 2014.

13.

Association of IL-17A and IL-17 F gene polymorphisms with recurrent pregnancy loss in Iranian women.

Najafi S, Hadinedoushan H, Eslami G, Aflatoonian A.

J Assist Reprod Genet. 2014 Nov;31(11):1491-6. doi: 10.1007/s10815-014-0294-0. Epub 2014 Sep 17.

14.

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.

Gaffen SL, Jain R, Garg AV, Cua DJ.

Nat Rev Immunol. 2014 Sep;14(9):585-600. doi: 10.1038/nri3707. Review.

15.

IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms.

Ha HL, Wang H, Pisitkun P, Kim JC, Tassi I, Tang W, Morasso MI, Udey MC, Siebenlist U.

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):E3422-31. doi: 10.1073/pnas.1400513111. Epub 2014 Aug 4.

16.

Interleukin-17 enhances immunosuppression by mesenchymal stem cells.

Han X, Yang Q, Lin L, Xu C, Zheng C, Chen X, Han Y, Li M, Cao W, Cao K, Chen Q, Xu G, Zhang Y, Zhang J, Schneider RJ, Qian Y, Wang Y, Brewer G, Shi Y.

Cell Death Differ. 2014 Nov;21(11):1758-68. doi: 10.1038/cdd.2014.85. Epub 2014 Jul 18.

17.

The differential regulation of human ACT1 isoforms by Hsp90 in IL-17 signaling.

Wu L, Wang C, Boisson B, Misra S, Rayman P, Finke JH, Puel A, Casanova JL, Li X.

J Immunol. 2014 Aug 15;193(4):1590-9. doi: 10.4049/jimmunol.1400715. Epub 2014 Jul 14.

18.

Downregulation of chicken interleukin-17 receptor A during Eimeria infection.

Kim WH, Jeong J, Park AR, Yim D, Kim S, Chang HH, Yang SH, Kim DH, Lillehoj HS, Min W.

Infect Immun. 2014 Sep;82(9):3845-54. doi: 10.1128/IAI.02141-14. Epub 2014 Jun 30.

19.

TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling.

Xiao Y, Jin J, Chang M, Nakaya M, Hu H, Zou Q, Zhou X, Brittain GC, Cheng X, Sun SC.

J Exp Med. 2014 Jul 28;211(8):1689-702. doi: 10.1084/jem.20132640. Epub 2014 Jun 30.

20.

Structure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved α-helix for Act1 binding and IL-17 signaling.

Zhang B, Liu C, Qian W, Han Y, Li X, Deng J.

Acta Crystallogr D Biol Crystallogr. 2014 May;70(Pt 5):1476-83. doi: 10.1107/S1399004714005227. Epub 2014 Apr 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk